[ April 18, 2024 ]
The drug has been 100% effective on high-risk for mortality patients. Under Trump’s right to try, it should be given to all deathly ill Corona patients.
But let’s respect the wishes of boycott the Jews (BDS) patients. They should not be treated with Israeli drugs or treatments.
Israeli COVID-19 treatment with 100% survival rate tested on US patient
Israeli-based Pluristem has treated its first American patient suffering from COVID-19 complications under the country’s compassionate use program.
Story continues below advertisementBy: Jerusalem Post, April 14, 2020:
The news comes days after a report by the company showed that six critically ill coronavirus patients in Israel who are considered high-risk for mortality were treated with Pluristem’s placenta-based cell-therapy product and survived, according to preliminary data provided by the Haifa-based company.
In the US case, the patient was treated with the company’s PLX cell therapy at Holy Name Medical Center in New Jersey, where Pluristem is already running a Phase III critical limb ischemia study. Like the patients treated in Israel, this patient was critically ill with respiratory failure due to acute respiratory distress syndrome and was intubated in an intensive care unit for three weeks.
The company’s president and CEO, Yaky Yanay, said that although Pluristem is focused on a planned multinational clinical trial for the treatment of complications associated with coronavirus, it does hope to expand treatment under compassionate use in other countries at the same time.
Specifically, the US treatment was administered under the US Food and Drug Administration’s Single Patient Expanded Access Program, which is part of the US Coronavirus Treatment Acceleration Program – an emergency program aimed at getting treatments to corona patients as quickly as possible.
In Israel, the six patients were treated at three different Israeli medical centers for one week, also under a compassionate use program. They were suffering from acute respiratory failure and inflammatory complications associated with COVID-19. Four of the six patients also demonstrated failure of other organ systems, including cardiovascular and kidney failure.
Not only had all the patients survived one week later, according to Pluristem, but four of them showed improvement in respiratory parameters and three of them are in the advanced stages of weaning from ventilators. Moreover, two of the patients with preexisting medical conditions are showing clinical recovery in addition to the respiratory improvement.Shortly after the preliminary data was published, Dr. Jason McCarthy, a senior managing director covering the biotechnology industry at Maxim Group praised Pluristem’s efforts: “Pluristem shows the COVID-19 world the first clinical data for stem cells,” he wrote. “Pluristem is initially evaluating its cell therapy under compassionate use authorization in Israel and is also the first company to dose COVID-19 patients, as well as produce the first set of early stage data.”
The company’s results were described by Yahoo! Finance as “promising to say the least.”
“Weighing in for H.C. Wainwright, analyst Swayampakula Ramakanth calls the early data ‘encouraging’ and thinks the treatment could drive substantial gains for PSTI,” the Yahoo! Finance article reported.
Pluristem’s PLX cells are “allogeneic mesenchymal-like cells that have immunomodulatory properties,” meaning they induce the immune system’s natural regulatory T cells and M2 macrophages, the company explained in a previous release. The result could be the reversal of dangerous overactivation of the immune system. This would likely reduce the fatal symptoms of pneumonia and pneumonitis (general inflammation of lung tissue).
Previous preclinical findings regarding PLX cells revealed significant therapeutic effects in animal studies of pulmonary hypertension, lung fibrosis, acute kidney injury and gastrointestinal injury.
“We are pleased with this initial outcome of the compassionate use program and committed to harnessing PLX cells for the benefit of patients and healthcare systems,” Yanay said.
The Truth Must be Told
Your contribution supports independent journalism
Please take a moment to consider this. Now, more than ever, people are reading Geller Report for news they won't get anywhere else. But advertising revenues have all but disappeared. Google Adsense is the online advertising monopoly and they have banned us. Social media giants like Facebook and Twitter have blocked and shadow-banned our accounts. But we won't put up a paywall. Because never has the free world needed independent journalism more.
Everyone who reads our reporting knows the Geller Report covers the news the media won't. We cannot do our ground-breaking report without your support. We must continue to report on the global jihad and the left's war on freedom. Our readers’ contributions make that possible.
Geller Report's independent, investigative journalism takes a lot of time, money and hard work to produce. But we do it because we believe our work is critical in the fight for freedom and because it is your fight, too.
Please contribute here.
or
Make a monthly commitment to support The Geller Report – choose the option that suits you best.
Quick note: We cannot do this without your support. Fact. Our work is made possible by you and only you. We receive no grants, government handouts, or major funding.Tech giants are shutting us down. You know this. Twitter, LinkedIn, Google Adsense, Pinterest permanently banned us. Facebook, Google search et al have shadow-banned, suspended and deleted us from your news feeds. They are disappearing us. But we are here.
Subscribe to Geller Report newsletter here— it’s free and it’s essential NOW when informed decision making and opinion is essential to America's survival. Share our posts on your social channels and with your email contacts. Fight the great fight.
Follow Pamela Geller on Gettr. I am there. click here.
Follow Pamela Geller on Trump's social media platform, Truth Social. It's open and free.
Remember, YOU make the work possible. If you can, please contribute to Geller Report.
Join The Conversation. Leave a Comment.
We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. If a comment is spammy or unhelpful, click the - symbol under the comment to let us know. Thank you for partnering with us to maintain fruitful conversation.
If you would like to join the conversation, but don't have an account, you can sign up for one right here.
If you are having problems leaving a comment, it's likely because you are using an ad blocker, something that break ads, of course, but also breaks the comments section of our site. If you are using an ad blocker, and would like to share your thoughts, please disable your ad blocker. We look forward to seeing your comments below.
13 Comments
4 years ago
The human furin cleavage with the insertion of HIV is the on switch for turning the auto immune system into a run away freight train and also KILLS the cilia… the infected can die of suffocation in their own mucous…
<<>>
TURN OFF THE AUTO IMMUNE SYSTEM
<<>>
Replenish the ZINC levels…
4 years ago
Reply to
whammie
“The human furin cleavage with the insertion of HIV…”
What on earth are you talking about???
4 years ago
Reply to
tedlv
If you do not want to take the time to research and learn who, what and why these ChiCom’s are responsible… I am not going to teach you…
<<>>
This was technology the U. of N. Carolina taught the ChiCom’s from the Wuhum Bio-Warfare Research Center after receiving MILLIONS of BRIBE DOLLARS… called “awards”… to teach the ChiComs how to make a HYBRID bio-weapon… known as CHIMERA…
<<>>
They should be charged with TREASON!!!
<<>>
The technique to cleave the helix… is called “GAIN OF FUNCTION”
<<>>
Dr. Francis A. Boyle… the author of the Bio-Terrorism Act of 1989-2000 explains this very concisely…
4 years ago
Reply to
whammie
Typical skank beotch negative malicious vote… Michelle is one sick FREAK…
LMAO @ U FREAK… I own you
4 years ago
Reply to
whammie
tedlv is obviously also of a room temp IQ… with little or no intelligence or reading comprehension skills…
<<>>
BAM there Teddie… you are BLOCKED…. go get yur GED… maybe Michelle and you can car pool…
<<>>
LMAO @ U
4 years ago
If this thing works I do not want any muzzies getting it, no BDS, Bernie doesn’t get any. The EU goes to the back of the line.
4 years ago
This is huge because it complements existing meds. In the hydroxychloroquine and azithromycin combo trials, patients were excluded from the study if they went to ICU. So those meds are good for moderate and serious cases, but not for very serious pneumonia cases. This new Pluristem helps where the others left off, with very serious pneumonia cases, in whom mortality is usually very high.
4 years ago
Reply to
DemocracyRules
My daughter is a nurse. When I discussed the medical combination you list, she said “people die from the combination.” I asked her for proof. Crickets.
4 years ago
Reply to
tedlv
She is right. People with certain heart ailments cannot take hydroxychloroquine. But most people find it safe. That’s why it’s an Rx med.
4 years ago
Reply to
DemocracyRules
My daughter thinks if one person has an adverse reaction, the drug is too dangerous to use. At times, she’s a little thick, and argumentative.
4 years ago
Reply to
tedlv
But you still love her… even though she thinks you are sometimes an overbearing know-it all…
4 years ago
Japan to offer anti-flu Avigan [favipiravir] drug to 20 virus-hit nations for free
https://www.japantimes.co.jp/news/2020/04/07/national/science-health/coronavirus-japan-avigan-20-nations-free/
Japan plans to provide the anti-flu drug Avigan [favipiravir] for free to 20 countries hoping to use it to treat coronavirus patients, Foreign Minister Toshimitsu Motegi said Tuesday. Prime Minister Shinzo Abe’s government plans to boost the stockpile of Avigan to three times the current amount for use in treating 2 million people infected with the new coronavirus.
Avigan [favipiravir] successfully inhibits Covid-19 in some cultured cells and protects mice against Ebola.
Researchers at Wuhan University and other institutions in China have said the drug was effective on coronavirus patients, especially for those with mild symptoms of Covid-19.
https://www.medicalnewstoday.com/articles/anti-flu-drug-effective-in-treating-covid-19
4 years ago
Good article, but is someone being paid by the word?
